A randomized control trial to study the effects of automated physician directed messaging on patient engagement in the digital diabetes prevention program

Brief description of study

The purpose of this study is to find out whether messages from providers (doctors) impact how people use diabetes prevention apps. This includes information on how often and when the app is used, and how likely people are to complete the recommended program.


Clinical Study Identifier: s20-01548
ClinicalTrials.gov Identifier: NCT04773834
Principal Investigator: Devin Mann.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.